Edition

Aurora Veteleanu

1

0

PhD Candidate, Neuroscience, Cardiff University

More research is needed to prove the drug slows cognitive decline. Atthapon Raksthaput/ Shutterstock

June 11, 2021

New Alzheimer’s drug aducanumab: what we know so far – and why more research is still needed

Eleftheria Kodosaki, Cardiff University and Aurora Veteleanu, Cardiff University

The first drug targeting Alzheimer’s disease has been approved in 20 years – but its approval isn’t based on substantial evidence.

Contact Aurora for

General
Media request
Speaking request
Research collaboration

Article Feed
Joined June 10, 2021